Journal of Clinical Densitometry
Volume 12, Issue 2 , Pages 135-157, April 2009

2008 Santa Fe Bone Symposium: Update on Osteoporosis

  • E. Michael Lewiecki

      Affiliations

    • New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA
    • Corresponding Author InformationAddress correspondence to: E. Michael Lewiecki, MD, FACP, FACE, New Mexico Clinical Research & Osteoporosis Center, 300 Oak St. NE, Albuquerque, NM 87106.
    • ,
  • Sanford Baim

      Affiliations

    • Colorado Center for Bone Research, Lakewood, CO, USA
    • ,
  • John P. Bilezikian

      Affiliations

    • Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
    • ,
  • Richard Eastell

      Affiliations

    • Academic Unit of Bone Metabolism, University of Sheffield, Sheffield, UK
    • ,
  • Meryl S. LeBoff

      Affiliations

    • Harvard Medical School, Boston, MA, USA
    • ,
  • Paul D. Miller

      Affiliations

    • Colorado Center for Bone Research, Lakewood, CO, USA

Received 9 December 2008; received in revised form 26 February 2009; accepted 26 February 2009.

Abstract 

The Ninth Annual Santa Fe Bone Symposium was held on August 1–2, 2008, in Santa Fe, New Mexico, USA. The symposium faculty presented the current best evidence on selected topics of clinical relevance in the fields of osteoporosis, metabolic bone disease, and assessment of skeletal health. The educational venues were in the form of didactic presentations, panel discussions, challenging cases, and numerous interactive discussions. Knowledge of basic science and clinical trials was applied to real-world patient scenarios that were discussed by faculty experts and clinician participants. Topics included an update on the rationale and development of new agents for the treatment of osteoporosis, the use of bone turnover markers in clinical practice, hospital-based pathways for the management of hip fracture patients, injectable bisphosphonates for the treatment of osteoporosis, combination therapy with anabolic and antiresorptive agents, and assessment of skeletal health with devices other than central dual-energy X-ray absorptiometry. This is a collection of scientific essays based on presentations and discussions at the 2008 Santa Fe Bone Symposium.

Key Words: BMD, bone turnover markers, FRAX, osteoporosis, review, treatment, update

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1094-6950(09)00015-8

doi:10.1016/j.jocd.2009.02.002

Journal of Clinical Densitometry
Volume 12, Issue 2 , Pages 135-157, April 2009

Article Tools

* Image Usage & Resolution